Leflunomide
Overview
Leflunomide is an immunomodulatory drug primarily used for the treatment of active moderate to severe rheumatoid arthritis. It works by inhibiting dihydroorotate dehydrogenase, an enzyme involved in pyrimidine synthesis, thus reducing lymphocyte proliferation.
API suppliers (8)
Suppliers of Leflunomide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
6 of 8 hold a GMP certificate on record in the EU or UK registers
- MAPRIMED SAArgentina1 active DMF GMP on record
- RAKSHIT DRUGS PRIVATE LTD1 active DMF
- EUROAPI GERMANY GMBHGermany1 active DMF GMP on record
- Cipla USA, Inc.USA1 active DMF
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
- Formosa Laboratories, Inc.Taiwan1 active DMF GMP on record
- Unichem Laboratories Ltd.India GMP on record
Therapeutic areas
Do you supply Leflunomide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.